New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
09:55 EDTBMYBristol to move forward with phase 3 trial of combo in first-line renal cancer
Bristol-Myers said it plans to move forward with a Phase 3 study of the combination of nivolumab and Yervoy in the first line setting with the objective of improving overall survival for renal cell cancers. The company also said that based upon "very promising data" from its 003 study that the company has accelerated the start of its Phase 3 program study 025, which is now completely enrolled. Comments made earlier on its ASCO highlights investor meeting.
News For BMY From The Last 14 Days
Check below for free stories on BMY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 17, 2014
07:43 EDTBMYBofA/Merrill to hold a conference
Subscribe for More Information
September 16, 2014
06:00 EDTBMYBristol-Myers announces Health Canada approval of Yervoy
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use